PRECISION: the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment.

Auteurs : Thouvenin J, Van Marcke C, Decoster L, Raicevic G, Punie K, Vandenbulcke M, Salgado R, Van Valckenborgh E, Maes B, Joris S, Steichel DV, Vranken K, Jacobs S, Dedeurwaerdere F, Martens G, Devos H, Duhoux FP, Rasschaert M, Pauwels P, Geboes K, Collignon J, Tejpar S, Canon JL, Peeters M, Rutten A, Van de Mooter T, Vermeij J, Schrijvers D, Demey W, Lybaert W, Van Huysse J, Mebis J, Awada A, Claes KBM, Hebrant A, Van der Meulen J, Delafontaine B, Bempt IV, Maetens J, de Hemptinne M, Rottey S, Aftimos P, De Grève J
Jaar : 2022
Journal : ESMO Open
Volume : 7
Pagina's : 100524

Efficacy of tyrosine kinase inhibitors for the treatment of patients with HER2-positive breast cancer with brain metastases: a systematic review and meta-analysis.

Auteurs : Nader-Marta G, Martins-Branco D, Agostinetto E, Bruzzone M, Ceppi M, Danielli L, Lambertini M, Kotecki N, Awada A, de Azambuja E
Jaar : 2022
Journal : ESMO Open
Volume : 7
Pagina's : 100501

Anthracyclines in the treatment of patients with early breast cancer.

Auteurs : Guarneri V, de Azambuja E
Jaar : 2022
Journal : ESMO Open
Volume : 7
Pagina's : 100461

Timelines to initiate a phase III trial across the globe: a sub-analysis of the APHINITY trial.

Auteurs : Franzoi MA, Procter M, Twelves C, Ponde N, Eiger D, Emond O, Clark E, Parlier D, Guillaume S, Reaby L, de Azambuja E, Bines J
Jaar : 2022
Journal : Ecancermedicalscience
Volume : 16
Pagina's : 1379

Timing evolution of lobular breast cancer through phylogenetic analysis.

Auteurs : Fimereli D, Venet D, Rediti M, Boeckx B, Maetens M, Majjaj S, Rouas G, Marchio C, Bertucci F, Mariani O, Capra M, Bonizzi G, Contaldo F, Galant C, Van den Eynden G, Salgado R, Biganzoli E, Vincent-Salomon A, Pruneri G, Larsimont D, Lambrechts D, Desmedt C, Brown DN, Rothé F, Sotiriou C
Jaar : 2022
Journal : EBioMedicine
Volume : 82
Pagina's : 104169

HTLV-1-related adult T-cell leukemia/lymphoma: insights in early detection and management.

Auteurs : Wolf S, Vercruyssen M, Cook L
Jaar : 2022
Journal : Curr Opin Oncol
Volume : 34
Pagina's : 446-453

Editorial: 'All you need is immunotherapy': a new treatment paradigm in sight for early-stage, mismatch repair-deficient/microsatellite instability high gastrointestinal cancers?

Auteurs : Sclafani F, Hendlisz A
Jaar : 2022
Journal : Curr Opin Oncol
Volume : 34
Pagina's : 379-381

Mind the target: human epidermal growth factor receptor 2 in colorectal cancer.

Auteurs : Saude Conde R, Rasschaert G, Bregni G, Hendlisz A, Sclafani F
Jaar : 2022
Journal : Curr Opin Oncol
Volume : 34
Pagina's : 382-388

Psychological interventions targeting patients with metastatic cancer and prolonged survival expectancies: advances and challenges.

Auteurs : Righes S, Lewis F, Waroquier P, Delevallez F, Merckaert I
Jaar : 2022
Journal : Curr Opin Oncol
Volume : 34
Pagina's : 256-264

How to support parenting in patients with cancer and co-parents? From research to practice.

Auteurs : Liénard A, Lamal S, Merckaert I
Jaar : 2022
Journal : Curr Opin Oncol
Volume : 34
Pagina's : 285-293

Editorial: Psychological interventions in oncology: advances and challenges.

Auteurs : Libert Y, Merckaert I, Klastersky JA
Jaar : 2022
Journal : Curr Opin Oncol
Volume : 34
Pagina's : 253-255

Biomarkers and immunotherapy: where are we?

Auteurs : Langouo Fontsa M, Padonou F, Willard-Gallo K
Jaar : 2022
Journal : Curr Opin Oncol
Volume : 34
Pagina's : 579-586

Molecular oncology: what is needed to speed access to innovative therapies in clinical research?

Auteurs : Gourari K, Awada A, Kotecki N
Jaar : 2022
Journal : Curr Opin Oncol
Volume : 34
Pagina's : 575-578

Cancer epitranscriptomics in a nutshell.

Auteurs : Primac I, Penning A, Fuks F
Jaar : 2022
Journal : Curr Opin Genet Dev
Volume : 75
Pagina's : 101924

An impact model to understand and improve work-life balance in early-career researchers in radiation oncology.

Auteurs : Pittens C, Dhont J, Petit S, Dubois L, Franco P, Mullaney L, Aznar M, Petit-Steeghs V, Bertholet J
Jaar : 2022
Journal : Clin Transl Radiat Oncol
Volume : 37
Pagina's : 101-108

Empiric versus pre-emptive antifungal strategy in high-risk neutropenic patients on fluconazole prophylaxis: a randomized trial of the European organization for Research and Treatment of cancer (EORTC 65091).

Auteurs : Maertens J, Lodewyck T, Peter Donnelly J, Chantepie S, Robin C, Blijlevens N, Turlure P, Selleslag D, Baron F, Aoun M, Heinz WJ, Bertz H, Vandercam B, Drgona L, Coiteux V, Llorente CC, Schaefer-Prokop C, Paesmans M, Ameye L, Meert L, Cheung KJ, Hepler DA, Loeffler J, Barnes R, Marchetti O, Verweij P, Lamoth F, Bochud PY, Schwarzinger M, Cordonnier C
Jaar : 2022
Journal : Clin Infect Dis
Volume : 76
Pagina's : 674-82

Effectiveness and Safety of Ibrutinib for Chronic Lymphocytic Leukemia in Routine Clinical Practice: 3-Year Follow-up of the Belgian Ibrutinib Real-World Data (BiRD) Study.

Auteurs : Janssens A, Berneman ZN, Offner F, Snauwaert S, Mineur P, Vanstraelen G, Meers S, Spoormans I, Bron D, Vande Broek I, Van Bogaert C, De Beleyr B, Smet A, Nielsen L, Wapenaar R, André M
Jaar : 2022
Journal : Clin Hematol Int
Volume : 4
Pagina's : 133-143

Morphological evaluation of melanocytic lesions with three-dimensional line-field confocal optical coherence tomography: correlation with histopathology and reflectance confocal microscopy. A pilot study.

Auteurs : Perez-Anker J, Puig S, Alos L, García A, Alejo B, Cinotti E, Orte Cano C, Tognetti L, Lenoir C, Monnier J, Machuca N, Castillo P, Gibert PR, Rubegni P, Suppa M, Perrot JL, Del Marmol V, Malvehy J
Jaar : 2022
Journal : Clin Exp Dermatol
Volume : 47
Pagina's : 2222-2233

Highlights from the 2022 ASCO gastrointestinal cancer symposium: An overview by the EORTC gastrointestinal tract cancer group.

Auteurs : Sclafani F, Fontana E, Wyrwicz L, Wagner AD, Valle JW, Smyth E, Peeters M, Obermannova R, Neuzillet C, Lutz MP, Koessler T, Ben-Aharon I, Arnold D, Alsina M, Moehler M
Jaar : 2022
Journal : Clin Colorectal Cancer
Volume : 21
Pagina's : 188-197

Unresectable and chemoresistant conjunctival squamous cell carcinoma on xeroderma pigmentosum treated by salvage radiation therapy: A case report and a review of the literature.

Auteurs : Maimouna M, Sofian B, Latifatou G, Joséphine Frédérique Mendouga E, Papa Macoumba G, Mamadou Moustapha D, Dirk VG
Jaar : 2022
Journal : Clin Case Rep
Volume : 10
Pagina's : e6360